Oral nicotinamide reduced the risk of new skin cancers—especially squamous cell carcinoma—by up to 54% when started after a ...

Once an association – even a small one – is established, researchers then must consider the extent to which causation can be claimed. One way to do this is through what’s called dose-response. This ...

Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...

The timing of hormone replacement therapy may make a big difference in a woman's risk of developing Alzheimer's disease.

Up to 32% lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women.

Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) The trials were ...

A new study recently put this popular eating plan to the test —  and the results were surprising. Here’s what you need to know.